0 Comentários
0 Compartilhamentos
1415 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Humira Biosimilar Market is Anticipated to Witness High Growth Owing to Patent Expiry of Reference DrugThe humira biosimilar market consists of biosimilar versions of the reference biologic drug Humira (adalimumab). Humira is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and others. The introduction of biosimilar versions of Humira provides a more cost effective treatment...0 Comentários 0 Compartilhamentos 1254 Visualizações 0 Anterior
- Humira Biosimilar Market Is Estimated To Witness High GrowthThe Humira Biosimilar Market is estimated to be valued at US$ 772.1 Million In 2023 and is expected to exhibit a CAGR of 25.9% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Humira is a monoclonal antibody used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriatic...0 Comentários 0 Compartilhamentos 1290 Visualizações 0 Anterior
- Humira Market Size, Analysis and Forecast 2031The Humira Market in 2023 is US$ 8.7 billion, and is expected to reach US$ 13.18 billion by 2031 at a CAGR of 5.33%. FutureWise Research published a report that analyzes Humira Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors...0 Comentários 0 Compartilhamentos 429 Visualizações 0 Anterior
- Let’s Understand the rise of Humira BiosimilarWhat are biosimilars?A biosimilar is a biologic medical product that is highly similar to an existing approved branded biologic product, known as the reference product or originator biologic. Biosimilars and their reference products have no clinically meaningful differences in terms of safety, purity, or potency. Biosimilars offer more treatment options and have the potential to reduce...0 Comentários 0 Compartilhamentos 1003 Visualizações 0 Anterior